Cancer Research Prevention Award Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hart, S.
Right arrow Articles by Ullrich, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hart, S.
Right arrow Articles by Ullrich, A.
[Cancer Research 64, 1943-1950, March 15, 2004]
© 2004 American Association for Cancer Research

Advances in Brief

Cannabinoids Induce Cancer Cell Proliferation via Tumor Necrosis Factor {alpha}-Converting Enzyme (TACE/ADAM17)-Mediated Transactivation of the Epidermal Growth Factor Receptor

Stefan Hart, Oliver M. Fischer and Axel Ullrich

Department of Molecular Biology, Max-Planck-Institute of Biochemistry, Martinsried, Germany

Cannabinoids, the active components of marijuana and their endogenous counterparts were reported as useful analgetic agents to accompany primary cancer treatment by preventing nausea, vomiting, and pain and by stimulating appetite. Moreover, they have been shown to inhibit cell growth and to induce apoptosis in tumor cells. Here, we demonstrate that anandamide, {Delta}9-tetrahydrocannabinol (THC), HU-210, and Win55,212-2 promote mitogenic kinase signaling in cancer cells. Treatment of the glioblastoma cell line U373-MG and the lung carcinoma cell line NCI-H292 with nanomolar concentrations of THC led to accelerated cell proliferation that was completely dependent on metalloprotease and epidermal growth factor receptor (EGFR) activity. EGFR signal transactivation was identified as the mechanistic link between cannabinoid receptors and the activation of the mitogen-activated protein kinases extracellular signal-regulated kinase 1/2 as well as prosurvival protein kinase B (Akt/PKB) signaling. Depending on the cellular context, signal cross-communication was mediated by shedding of proAmphiregulin (proAR) and/or proHeparin-binding epidermal growth factor-like growth factor (proHB-EGF) by tumor necrosis factor {alpha} converting enzyme (TACE/ADAM17). Taken together, our data show that concentrations of THC comparable with those detected in the serum of patients after THC administration accelerate proliferation of cancer cells instead of apoptosis and thereby contribute to cancer progression in patients.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
F. Cianchi, L. Papucci, N. Schiavone, M. Lulli, L. Magnelli, M. C. Vinci, L. Messerini, C. Manera, E. Ronconi, P. Romagnani, et al.
Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor {alpha}-Mediated Ceramide De novo Synthesis in Colon Cancer Cells
Clin. Cancer Res., December 1, 2008; 14(23): 7691 - 7700.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Iribarne, V. Torbidoni, K. Julian, J. P. Prestifilippo, D. Sinha, V. Rettori, A. Berra, and A. M. Suburo
Cannabinoid Receptors in Conjunctival Epithelium: Identification and Functional Properties
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4535 - 4544.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Zhang, J. F. Wang, G. Kunos, and J. E. Groopman
Cannabinoid Modulation of Kaposi's Sarcoma Associated Herpesvirus Infection and Transformation
Cancer Res., August 1, 2007; 67(15): 7230 - 7237.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
S. Langlois, C. Nyalendo, G. Di Tomasso, L. Labrecque, C. Roghi, G. Murphy, D. Gingras, and R. Beliveau
Membrane-Type 1 Matrix Metalloproteinase Stimulates Cell Migration through Epidermal Growth Factor Receptor Transactivation
Mol. Cancer Res., June 1, 2007; 5(6): 569 - 583.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
P. Pacher, S. Batkai, and G. Kunos
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
R. Mehra, B. A. Moore, K. Crothers, J. Tetrault, and D. A. Fiellin
The association between marijuana smoking and lung cancer: a systematic review.
Arch Intern Med, July 10, 2006; 166(13): 1359 - 1367.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Carracedo, M. Gironella, M. Lorente, S. Garcia, M. Guzman, G. Velasco, and J. L. Iovanna
Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic Reticulum Stress-Related Genes.
Cancer Res., July 1, 2006; 66(13): 6748 - 6755.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
N. M. Kogan, C. Blazquez, L. Alvarez, R. Gallily, M. Schlesinger, M. Guzman, and R. Mechoulam
A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells
Mol. Pharmacol., July 1, 2006; 70(1): 51 - 59.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
M. Tascilar, F. A. de Jong, J. Verweij, and R. H. J. Mathijssen
Complementary and Alternative Medicine During Cancer Treatment: Beyond Innocence
Oncologist, July 1, 2006; 11(7): 732 - 741.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. Berghuis, M. B. Dobszay, X. Wang, S. Spano, F. Ledda, K. M. Sousa, G. Schulte, P. Ernfors, K. Mackie, G. Paratcha, et al.
Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor
PNAS, December 27, 2005; 102(52): 19115 - 19120.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Tanaka, S. Miyamoto, S. O. Suzuki, E. Oki, H. Yagi, K. Sonoda, A. Yamazaki, H. Mizushima, Y. Maehara, E. Mekada, et al.
Clinical Significance of Heparin-Binding Epidermal Growth Factor-Like Growth Factor and A Disintegrin and Metalloprotease 17 Expression in Human Ovarian Cancer
Clin. Cancer Res., July 1, 2005; 11(13): 4783 - 4792.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
F. A. de Jong, F. K. Engels, R. H.J. Mathijssen, L. van Zuylen, J. Verweij, R. P.H. Peters, and A. Sparreboom
Medicinal Cannabis in Oncology Practice: Still a Bridge Too Far?
J. Clin. Oncol., May 1, 2005; 23(13): 2886 - 2891.
[Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
I. Tegeder and G. Geisslinger
Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications
Pharmacol. Rev., September 1, 2004; 56(3): 351 - 369.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.